Alector
We are on a mission to make brain disorders history.
141 employees · est. 2013 · South San Francisco, United...
Vigil Neuroscience
Harnessing the power of microglia to transform treatments for neurodegenerative diseases
76 employees · est. 2020 · Watertown, United States
Alector is the older company (2013 vs 2020).
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Alector | Vigil Neuroscience |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2020 |
| Headquarters | ||
| Headquarters | South San Francisco, United States | Watertown, United States |
| Employees | ||
| Employees | 141 | 76 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | IPO | Acquired |
| Total Funding | ||
| Total Funding | $495.50M | $650.00M |
| Funding Rounds | ||
| Funding Rounds | 8 | 5 |
| Services | ||
| Services | Development of therapies for neurodegenerative diseases, Conducting clinical trials, Research in human genetics, neuroscience, and immunology | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with neurodegenerative diseases, Healthcare providers, Research institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Neurodegenerative Diseases, Clinical Development, Antibody Discovery, Protein Engineering, Blood-Brain Barrier Technology, Alzheimer's Disease, Neuroimmunology, Genetic Targeting, Therapeutic Development, Neuroscience, Innovative Therapies, Drug Development, Lysosomal Dysfunction, Immune System Restoration | Neurodegenerative Diseases, Microglia, Clinical-stage, Therapeutic Modalities, Precision-based Therapies, Monoclonal Antibodies, TREM2 Agonist, Alzheimer's Disease, Series A Funding, Neuroscience, Drug Development, Phase 1 Studies, IND, Pipeline Expansion |
| Website | ||
| Website | alector.com | vigilneuro.com |
About Alector
Alector, founded in 2013 and headquartered in the United States, is a cutting-edge player in the Biotechnology sector, focused on transforming approaches to Health Care and Pharmaceuticals. With the bold mission "to make brain disorders history," Alector is anchored in a late-stage clinical phase wi...
About Vigil Neuroscience
Vigil Neuroscience is a clinical-stage biotechnology company established in 2020 with a focus on developing treatments for neurodegenerative diseases. The company's slogan, "Harnessing the power of microglia to transform treatments for neurodegenerative diseases," underlines its innovative approach....
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Alector and Vigil Neuroscience — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Alector and Vigil Neuroscience — by email.
Frequently Asked Questions
Compare Alector with someone else
Start typing a company name or domain.